Developing and testing sickle cell trait awareness messages to strive towards consistent and accurate education
DOI:
https://doi.org/10.18203/2394-6040.ijcmph20251680Keywords:
Sickle cell trait awareness, Health communication, Consolidated framework for implementation research, Nominal group technique, StakeholderAbstract
Background: Sickle cell trait is often misrepresented as benign, leading to misinformation and a lack of awareness about potential health complications. In the United States, 1 in 13 Black individuals are affected, though people of any race or ethnicity can have the condition. Misconceptions, systemic racism, and underfunded research contribute to inconsistent communication and education. To that end, this initiative aimed to identify gaps in awareness and education and develop consistent, comprehensive, scientifically informed messages to improve public understanding. The goal was for these messages to be adopted by sickle cell trait organizations nationwide to promote consistency in education and communication.
Methods: Using a mixed-methods approach, 19 key stakeholders including sickle cell organizations, medical experts, and individuals with sickle cell trait were engaged to identify communication gaps. The consolidated framework for implementation research (CFIR) guided survey and interview analysis, ensuring a structured approach to understanding stakeholder perspectives. The nominal group technique (NGT) validated findings during expert meetings, helping achieve consensus on messaging before testing with the sickle cell trait community.
Results: Findings highlighted inconsistent messaging, limited public understanding, insufficient research funding, and inadequate provider knowledge. Stakeholders and community members stressed the need for accurate, culturally sensitive, consistent, and accessible messaging to improve awareness and patient-provider communication.
Conclusions: Through collaboration and community validation, evidence-based messages were developed to promote informed decision-making, encourage self-advocacy, and enhance provider-patient communication. Standardized messaging is essential to combat misinformation, raise awareness, and improve health outcomes for individuals with sickle cell trait.
Metrics
References
Piel FB, Patil AP, Howes RE, Nyangiri OA, Gething PW, Williams TN, et al. Global distribution of the sickle cell gene and geographical confirmation of the malaria hypothesis. Nat Commun. 2010;1(1):104. DOI: https://doi.org/10.1038/ncomms1104
Kotila TR. Sickle Cell Trait: A Benign State? Acta Haematol. 2016;136(3):147–51. DOI: https://doi.org/10.1159/000446526
Centers for Disease Control and Prevention. 2019. Sickle Cell Trait Toolkit | CDC. Available at: https://www.cdc.gov/ncbddd/sicklecell/toolkit.html. Accessed on 30 May 2023.
Msaouel P, Rao P, Tannir NM. Renal Medullary Carcinoma. In: Malouf GG, Tannir NM, editors. Rare Kidney Tumors: Comprehensive Multidisciplinary Management and Emerging Therapies. Cham: Springer International Publishing; 2019;65-75. DOI: https://doi.org/10.1007/978-3-319-96989-3_6
Kiryluk K, Jadoon A, Gupta M, Radhakrishnan J. Sickle cell trait and gross hematuria. Kidney International. 2007;71(7):706-10. DOI: https://doi.org/10.1038/sj.ki.5002060
COCHRAN RT Jr. Hyposthenuria in Sickle Cell States. Archives of Internal Medicine. 1963;112(2):222-5. DOI: https://doi.org/10.1001/archinte.1963.03860020120016
Edwards JK. Sickle cell trait increases the risk of chronic kidney disease. Nat Rev Nephrol. 2015;11(2):65-5. DOI: https://doi.org/10.1038/nrneph.2014.229
Folsom AR, Tang W, Roetker NS, Kshirsagar AV, Derebail VK, Lutsey PL, et al. Prospective study of sickle cell trait and venous thromboembolism incidence. J Thromb Haemost. 2015;13(1):2-9. DOI: https://doi.org/10.1111/jth.12787
Goodman J, Hassell K, Irwin D, Witkowski EH, Nuss R. The Splenic Syndrome in Individuals with Sickle Cell Trait. High Alt Med Biol. 2014;15(4):468-71. DOI: https://doi.org/10.1089/ham.2014.1034
Harrelson GL, Fincher AL, Robinson JB. Acute Exertional Rhabdomyolysis and Its Relationship to Sickle Cell Trait. J Athl Train. 1995;30(4):309-12.
Jones SR, Binder RA, Donowho EM. Sudden Death in Sickle-Cell Trait. New England Journal of Medicine. 1970;282(6):323-5. DOI: https://doi.org/10.1056/NEJM197002052820607
Crossan A, Sandler S, Yao WJ (Melissa). The prevalence of primary open angle glaucoma among sickle cell patients in the Bronx. Investigative Ophthalmology & Visual Science. 2014;55(13):4275.
Tsaras G, Owusu-Ansah A, Boateng FO, Amoateng-Adjepong Y. Complications associated with sickle cell trait: a brief narrative review. Am J Med. 2009;122(6):507-12. DOI: https://doi.org/10.1016/j.amjmed.2008.12.020
Sickle Cell Research Priorities. Available at: https://www.hematology.org/research/sickle-cell-disease-and-sickle-cell-trait/sickle-cell-research-priorities. Accessed on 23 June 2023.
Power-Hays A, McGann PT. When Actions Speak Louder Than Words — Racism and Sickle Cell Disease. New England Journal of Medicine. 2020;383(20):1902-3. DOI: https://doi.org/10.1056/NEJMp2022125
Creary S, Adan I, Stanek J, O’Brien SH, Chisolm DJ, Jeffries T, et al. Sickle cell trait knowledge and health literacy in caregivers who receive in-person sickle cell trait education. Mol Genet Genomic Med. 2017;5(6):692-9. DOI: https://doi.org/10.1002/mgg3.327
Promoting Sickle Cell Trait Awareness and Education: A Typology of Interventions in the United States to Inform Ongoing Efforts to Patients and Providers. Available at: https://www.scirp.org/journal/paperinformation?paperid=132490. Accessed on 16 Decembre 2024. DOI: https://doi.org/10.4236/health.2024.164022
Damschroder LJ, Aron DC, Keith RE, Kirsh SR, Alexander JA, Lowery JC. Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science. Implementation Sci. 2009;4(1):50. DOI: https://doi.org/10.1186/1748-5908-4-50
Manera K, Hanson CS, Gutman T, Tong A. Consensus Methods: Nominal Group Technique. In: Liamputtong P, editor. Handbook of Research Methods in Health Social Sciences. Singapore: Springer; 2019737–50.
Framework for Program Evaluation - CDC. 2023 Available at: https://www.cdc.gov/evaluation/framework/index.htm. Accessed on 21 June 2023.
Mc Sharry J, Fredrix M, Hynes L, Byrne M. Prioritising target behaviours for research in diabetes: Using the nominal group technique to achieve consensus from key stakeholders. Res Involv Engagem. 2016;2(1):14. DOI: https://doi.org/10.1186/s40900-016-0028-9
Claxton JD, Ritchie JRB, Zaichkowsky J. The Nominal Group Technique: Its Potential for Consumer Research. Journal of Consumer Research. 1980;7(3):308-13. DOI: https://doi.org/10.1086/208818
Fink A, Kosecoff J, Chassin M, Brook RH. Consensus methods: characteristics and guidelines for use. Am J Public Health. 1984;74(9):979-83. DOI: https://doi.org/10.2105/AJPH.74.9.979
Lumivero. NVivo. 2022. Available at: https://lumivero.com/products/nvivo/. Accessed on 3 March 2025.
Qualtrics. Qualtrics. Provo, Utah; 2025. Available at: https://www.qualtrics.com/. Accessed on 3 March 2025.
Dunn DS, Andrews EE. Person-first and identity-first language: Developing psychologists’ cultural competence using disability language. American Psychologist. 2015;70(3):255-64. DOI: https://doi.org/10.1037/a0038636
Austin H, Key NS, Benson JM, Lally C, Dowling NF, Whitsett C, et al. Sickle cell trait and the risk of venous thromboembolism among blacks. Blood. 2007;110(3):908-12. DOI: https://doi.org/10.1182/blood-2006-11-057604
Breimaier HE, Heckemann B, Halfens RJG, Lohrmann C. The Consolidated Framework for Implementation Research (CFIR): a useful theoretical framework for guiding and evaluating a guideline implementation process in a hospital-based nursing practice. BMC Nurs. 2015;14(1):43. DOI: https://doi.org/10.1186/s12912-015-0088-4
Roennow A, Sauvé M, Welling J, Riggs RJ, Kennedy AT, Galetti I, et al. Collaboration between patient organisations and a clinical research sponsor in a rare disease condition: learnings from a community advisory board and best practice for future collaborations. BMJ Open. 2020;10(12):e039473. DOI: https://doi.org/10.1136/bmjopen-2020-039473
Smerecnik CMR, Mesters I, de Vries NK, de Vries H. Educating the general public about multifactorial genetic disease: applying a theory-based framework to understand current public knowledge. Genetics in Medicine. 2008;10(4):251–8. DOI: https://doi.org/10.1097/GIM.0b013e31816b4ffd
Robert Kaplan, Michael Spittel, Daryn David. Population Health: Behavioral and Social Science Insights. Understanding the relationship between education and health: a review of the evidence and an examination of community perspectives. Population Health: Behavioral and Social Science Insights; 2015.
Farrell MH, La Pean Kirschner A, Tluczek A, Farrell PM. Experience with Parent Follow-Up for Communication Outcomes after Newborn Screening Identifies Carrier Status. The Journal of Pediatrics. 2020;224:37-43.e2. DOI: https://doi.org/10.1016/j.jpeds.2020.03.027
DeLuca JM, Kearney MH, Norton SA, Arnold GL. Parents’ Experiences of Expanded Newborn Screening Evaluations. Pediatrics. 2011;128(1):53-61. DOI: https://doi.org/10.1542/peds.2010-3413
Full article: Improving health outcomes with better patient understanding and education. Available at: https://www.tandfonline.com/doi/full/10.2147/RMHP.S7500. Accessed on 13 Decembre 2024.
Goldsmith JC, Bonham VL, Joiner CH, Kato GJ, Noonan AS, Steinberg MH. Framing the research agenda for sickle cell trait: building on the current understanding of clinical events and their potential implications. Am J Hematol. 2012;87(3):340-6. DOI: https://doi.org/10.1002/ajh.22271
36. Gallo AM, Wilkie D, Suarez M, Labotka R, Molokie R, Thompson A, et al. Reproductive Decisions in People With Sickle Cell Disease or Sickle Cell Trait. West J Nurs Res. 2010;32(8):1073-90. DOI: https://doi.org/10.1177/0193945910371482
Gallo AM, Wilkie DJ, Yao Y, Molokie RE, Stahl C, Hershberger PE, et al. Reproductive Health CHOICES for Young Adults with Sickle Cell Disease or Trait: Randomized Controlled Trial Outcomes over Two Years. Journal of Genetic Counseling. 2016;25(2):325-36. DOI: https://doi.org/10.1007/s10897-015-9874-0
Brownson RC, Fielding JE, Maylahn CM. Evidence-Based Public Health: A Fundamental Concept for Public Health Practice. Annual Review of Public Health. 2009;30:175-201. DOI: https://doi.org/10.1146/annurev.publhealth.031308.100134
Náfrádi L, Nakamoto K, Schulz PJ. Is patient empowerment the key to promote adherence? A systematic review of the relationship between self-efficacy, health locus of control and medication adherence. PLOS ONE. 2017;12(10):e0186458. DOI: https://doi.org/10.1371/journal.pone.0186458
Abualrahi AAA, Banna DSMRE, Abdou DNM. Effect of an Empowerment Program on Self-Efficacy and Coping of Adults with Sickle Cell Disease. Journal of International Crisis and Risk Communication Research. 2024;1123-34. DOI: https://doi.org/10.63278/jicrcr.vi.657